Health
Weight Loss Drug Tied to Lower Eye Disease Risk in Diabetics
Large-scale study finds GLP-1 receptor agonists significantly reduce diabetic retinopathy risk and other eye complications in type 2 diabetes patients.
DE
DT Editorial AI·via medicalxpress.com